Sabby Management’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-147,926
Closed -$141K 424
2015
Q3
$141K Sell
147,926
-8,100
-5% -$13K 0.01% 358
2015
Q2
$415K Sell
156,026
-99,409
-39% -$340K 0.02% 266
2015
Q1
$999K Sell
255,435
-58,932
-19% -$250K 0.04% 189
2014
Q4
$1.33K Buy
314,367
+25,257
+9% +$109K 0.04% 147
2014
Q3
$1.21K Buy
+289,110
New +$1.57M 0.05% 147

Other funds holding SKBI

Sabby Management's SKBI Position: Q4 2015 in Review

Sabby Management sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q4 2015, closing a stake of 147,926 shares — an estimated $141K sold.

Sabby Management first reported a position in SKBI in Q3 2014 and held it in 5 quarters. The position peaked at $999K in Q1 2015. 1 fund tracked by Wall St. Rank holds SKBI as of Q4 2015.

  • Sabby Management reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q4 2015 after selling out during the quarter.
  • Sabby Management sold 147,926 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q4 2015, an estimated $141K.
  • Sabby Management first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q3 2014 and held it in 5 quarters.
  • Sabby Management's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $999K in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q4 2015.

Based on Sabby Management's 13F filing for Q4 2015, filed 16 Feb 2016.